23andMe has appointed Dean Schorno its CFO and head of operations. He will oversee 23andMe's global financial and clinical laboratory operations. Schorno was most recently CFO of Adaptive Biotechnologies. Before that he held executive leadership positions at Genomic Health.
Arthur Beaudet, Laurel Estabrooks, Laura Furmanski, Anthony Romaine Gregg